Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories–indications for novel treatments of addiction

BJ Everitt - European Journal of Neuroscience, 2014 - Wiley Online Library
This review discusses the evidence for the hypothesis that the development of drug
addiction can be understood in terms of interactions between Pavlovian and instrumental …

Obesity: Current and potential pharmacotherapeutics and targets

V Narayanaswami, LP Dwoskin - Pharmacology & therapeutics, 2017 - Elsevier
Obesity is a global epidemic that contributes to a number of health complications including
cardiovascular disease, type 2 diabetes, cancer and neuropsychiatric disorders …

Opioid hedonic hotspot in nucleus accumbens shell: mu, delta, and kappa maps for enhancement of sweetness “liking” and “wanting”

DC Castro, KC Berridge - Journal of Neuroscience, 2014 - Soc Neuroscience
A specialized cubic-millimeter hotspot in the rostrodorsal quadrant of medial shell in nucleus
accumbens (NAc) of rats may mediate opioid enhancement of gustatory hedonic impact or …

Hormonal and neural mechanisms of food reward, eating behaviour and obesity

S Murray, A Tulloch, MS Gold, NM Avena - Nature Reviews …, 2014 - nature.com
With rising rates of obesity, research continues to explore the contributions of homeostatic
and hedonic mechanisms related to eating behaviour. In this Review, we synthesize the …

Behavioral addictions

TW Robbins, L Clark - Current opinion in neurobiology, 2015 - Elsevier
Highlights•What the new DSM-5 means for the concept of behavioral addiction.•Common
theoretical framework for substance addiction, behavioral addictions and OCD.•Pathological …

Obesity is associated with decreased μ-opioid but unaltered dopamine D2 receptor availability in the brain

HK Karlsson, L Tuominen, JJ Tuulari… - Journal of …, 2015 - Soc Neuroscience
Neurochemical pathways involved in pathological overeating and obesity are poorly
understood. Although previous studies have shown increased μ-opioid receptor (MOR) and …

[HTML][HTML] Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss

SK Billes, P Sinnayah, MA Cowley - Pharmacological research, 2014 - Elsevier
The mechanism of action of the combination therapy, naltrexone/bupropion (NB), for obesity
has not been fully described to date. Weight loss attempts rarely result in long-term success …

[HTML][HTML] Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone

A Mallik, ML Chanda, DJ Levitin - Scientific reports, 2017 - nature.com
Music's universality and its ability to deeply affect emotions suggest an evolutionary origin.
Previous investigators have found that naltrexone (NTX), a μ-opioid antagonist, may induce …

[HTML][HTML] Pathological overeating: emerging evidence for a compulsivity construct

CF Moore, V Sabino, GF Koob, P Cottone - Neuropsychopharmacology, 2017 - nature.com
Compulsive eating behavior is a transdiagnostic construct that is characteristic of medical
and psychiatric conditions such as forms of obesity and eating disorders. Although feeding …

Overlap of food addiction and substance use disorders definitions: analysis of animal and human studies

A Hone-Blanchet, S Fecteau - Neuropharmacology, 2014 - Elsevier
Food has both homeostatic and hedonic components, which makes it a potent natural
reward. Food related reward could therefore promote an escalation of intake and trigger …